SGLT2i reduces outcomes in HFmrEF and HFpEF regardless of glycemic status
Prof. John Buse, MD, PhD
Prof. Peter Rossing, MD
Marta Seghieri, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.